Skip to main content

MedAvail Holdings, Inc. (MDVLQ)

New York Stock Exchange Healthcare Medical - PharmaceuticalsView data quality →
47.1Fair

ValueMarkers Composite Index

Top 19%#36,415 of 44,707

DCF data not available

Piotroski
4/9
Neutral
Beneish
-1.96
Investigate
Altman
-12.80
Distress
DCF Value
-
N/A
ROIC
-166.4%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

MedAvail Holdings, Inc. (MDVLQ) — VMCI valuation read

MDVLQ screens at VMCI 47/100, a 3-point gap below the Healthcare sector median (50). For a mid-cap MedAvail Holdings, Inc. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

MDVLQ has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: MDVLQ trades at 18.0x earnings, 0% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 1.9x is the rate-sensitivity line to watch, which sets the rate-cycle exposure for MedAvail Holdings, Inc..

MDVLQ rose 2.5% over the trailing 7 days, with a +1.8% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in MDVLQ’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.